Anlon Healthcare Limited Revises Acquisition Percentages for APIqo Organics and Bizotic Lifescience, Details Share Swap Transaction

Anlon Healthcare Limited Revises Acquisition Percentages for APIqo Organics and Bizotic Lifescience, Details Share Swap Transaction​

Anlon Healthcare Limited has announced a revision regarding the acquisition of shares in Apiqo Organics Private Limited (AOPL) and Bizotic Lifescience Private Limited (BLPL), clarifying the exact percentage of acquisition. The company confirmed that the correct acquisition percentages are 44.94% in AOPL and 47.41% in BLPL, correcting previous figures where 32.52% and 43.33% were inadvertently mentioned.

The acquisitions, which fall under a Related Party Transaction, are aimed at strengthening critical material supply chains for Anlon Healthcare Limited, achieving strategic synergies, and enhancing long-term shareholder value. Both transactions are structured as a share swap agreement, with no cash consideration expected to be payable.

Acquisition of Apiqo Organics Private Limited (AOPL)​

The acquisition in AOPL is intended to strengthen the supply chain for Anlon Healthcare Limited. Details concerning this acquisition include:


The acquisition in AOPL is subject to the acceptance of the share swap proposal by all shareholders of the target company. Financials for AOPL show turnover during the last three years as follows:

Acquisition of Bizotic Lifescience Private Limited (BLPL)​

The acquisition in BLPL is focused on enhancing operational efficiency and achieving strategic synergies for the company. The details are as follows:


Similar to the AOPL transaction, the acquisition in BLPL is contingent upon the acceptance of the share swap proposal by all shareholders. Financial details for BLPL over the last three years are summarized below:

Details of Preferential Allotment and Share Swap​

The transactions involve the issuance of equity shares through a preferential allotment for consideration other than cash (share swap). The total number of securities proposed to be issued across both AOPL and BLPL is subject to approval and amounts to up to 8,58,83,617 Equity Shares. All these shares are classified as Equity Shares with a face value of Rs.02/- per share.

The issue price for the equity shares in this preferential allotment was disclosed at Rs.17.85/- per equity share. The outcome of the subscription and subsequent shareholding adjustments for both target companies were reported, indicating changes to the pre-preferential holding figures following the planned allotment.

AHCL Stock Price Movement​

Shares of Anlon Healthcare Limited are edging higher to ₹14.32 as of 2:32 PM today, reflecting a solid gain of 0.63%. In live trading, the stock has seen a volume totaling 944,700 shares.